In parallel with these events, the activation of intestinal FXR induces intestinal epithelial cells to release FGF15/19 into the liver, effectively diminishing hepatic steatosis and enhancing insulin resistance [149,150,151,152]. Here, NR1H4 is linked to fatty liver disease.